RANGER™ DRUG-COATED BALLOON

Delivering above
and beyond

Overview

Eluvia DES

Eluvia Technology

Eluvia Clinical Trials

Ranger DCB

Ranger Technology

Ranger Clinical Trials

Resources

Vascular Surgery / Drug-Eluting Therapies / Ranger DCB / Ranger DCB Technology

View of medical professional's back of head wearing a surgical mask

NEXT-GENERATION TECHNOLOGY

Innovation for effortless deliverability.

Ranger™ Drug-Coated Balloon is built on the physician preferred Sterling™ 0.014”/0.018" balloon platform¹ with the lowest tip entry profile of any SFA DCB² and highly efficient drug transfer into the tissue. Ranger DCB delivers like nothing else.

The Lowest Tip Entry Profile of Any SFA DCB²

Ranger DCB's low profile and tapered tip enables a smooth delivery with excellent trackability and navigation through alternative access³ sites.

Efficient Drug Transfer

TransPax™ (citrate ester + low dose paclitaxel) is a next-generation coating that enables highly efficient drug transfer into the lesion.

Infographic showing TransPax is lipophilic and TransPax is hydrophobic.

Ranger DCB Product Details

Ranger DCB has a comprehensive matrix and is compatible with pedal access³

3. Boston Scientific Data on File. Ranger Catheter Competitive Testing Report, 92517674. Ranger diameters ≤6mm, testing done with Terumo GLIDESHEATH SLENDER™ 5F.

Proprietary Loading Tool

Serves as the balloon and drug protector to help prevent drug loss during insertion and limit a physician’s exposure to the drug.

1. DRG Data, CY 2020, 0.018" PTA Balloons.
2. Boston Scientific Data on File. Ranger Catheter Competitive Testing Report, 92517674. Measurements taken from 6 x 120 devices for Ranger DCB, Lutonix™ 035 DCB, IN.PACT Admiral DCB and Stellarex™ 035 DCB. Lutonix 018 DCB measurements taken from 6 x 150 devices.
3. Boston Scientific Data on File. Ranger Catheter Competitive Testing Report, 92517674. Ranger diameters ≤6mm, testing done with Terumo GLIDESHEATH SLENDER™ 5F.

Legs and feet of patient sitting on bed with hands on lap.

RESTENOSIS REPLACEMENT PROGRAM

Standing together.

The Bold Step Program is a statement of our confidence in the efficacy of our drug-eluting products. The program offers an Eluvia DES or Ranger DCB at no additional charge if a patient requires reintervention within the first year due to restenosis.